Login / Signup

Comparative Genomics Identifies Novel Genetic Changes Associated with Oxacillin, Vancomycin and Daptomycin Susceptibility in ST100 Methicillin-Resistant Staphylococcus aureus .

Sabrina Di GregorioMaría Sol HaimÁngela María Rosa FamigliettiJosé Alejandro Di ConzaMarta Mollerach
Published in: Antibiotics (Basel, Switzerland) (2023)
Infections due to vancomycin-intermediate S. aureus (VISA) and heterogeneous VISA (hVISA) represent a serious concern due to their association with vancomycin treatment failure. However, the underlying molecular mechanism responsible for the hVISA/VISA phenotype is complex and not yet fully understood. We have previously characterized two ST100-MRSA-hVISA clinical isolates recovered before and after 40 days of vancomycin treatment (D1 and D2, respectively) and two in vitro VISA derivatives (D23C9 and D2P11), selected independently from D2 in the presence of vancomycin. This follow-up study was aimed at further characterizing these isogenic strains and obtaining their whole genome sequences to unravel changes associated with antibiotic resistance. It is interesting to note that none of these isogenic strains carry SNPs in the regulatory operons vraUTSR , walKR and/or graXRS . Nonetheless, genetic changes including SNPs, INDELs and IS 256 genomic insertions/rearrangements were found both in in vivo and in vitro vancomycin-selected strains. Some were found in the downstream target genes of the aforementioned regulatory operons, which are involved in cell wall and phosphate metabolism, staphylococcal growth and biofilm formation. Some of the genetic changes reported herein have not been previously associated with vancomycin, daptomycin and/or oxacillin resistance in S. aureus .
Keyphrases
  • methicillin resistant staphylococcus aureus
  • staphylococcus aureus
  • genome wide
  • biofilm formation
  • escherichia coli
  • copy number
  • dna methylation
  • cell wall
  • pseudomonas aeruginosa
  • transcription factor
  • gene expression